Breaking News

Samsung BioLogics Signs CMO Contract

Deal valued at $105 million

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Samsung BioLogics has signed a CMO contract with an Asian pharmaceutical company. This contract is in addition to an already existing manufacturing contract. The approximate value of the contract will be $105 million for one year in 2018. The company said other terms of the agreement related to company’s name, product, and production factory will not be disclosed.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters